Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system.

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

Though the Medtronic OmniaSecure is the world's smallest defibrillation lead, the product development story isn't one of ...

Following concerns that Medtronic was overspending on the high-tech system and not developing it fast enough, FDA clearance ...

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...

Medtronic PLC, a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $118.65 billion, reported its first-quarter fiscal 2026 earnings, surpassing Wall ...

Medical device-maker Medtronic has agreed to acquire peer Covidien for $42.9 billion in cash and stock. The purchase values Covidien at $93.22 per Covidien share. Covidien closed at $72.02 on Friday. ...

Good morning. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations, and I appreciate that you're joining us for our Fiscal ‘25 Fourth Quarter Video Earnings Webcast. Before ...

MINNEAPOLIS & SUNNYVALE, Calif.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) and Kyphon (NASDAQ:KYPH) today announced that the companies have signed a definitive merger agreement under which Medtronic ...

Different growth rates are projected across sectors: Cardiovascular (7.9%), Medical Surgical (9.4%), Neuroscience (5.95%), and Diabetes (9.8%). The company plans to embrace digital technologies and ...

Medtronic plc (NYSE:MDT) Q2 2026 Earnings Call Transcript November 18, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.36, expectations were $1.31. Ryan Weispenning: Hello, everyone ...